Table of Contents

Foreword<br>Introduction<br>1 Scope<br>2 Symbols and abbreviated terms<br>3 Framework<br>4 Terminology development within the clinical value chain<br>Annex A (informative) - Nanomedicine terms as defined<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in current literature<br>Annex B (informative) - Nanomedicine ontology and<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;terminology resources<br>Bibliography

Abstract

Assists communications between developers and users of nanotechnologies, deliverers and users of medicine including the pharmaceutical, research and medical communities, regulatory professionals, and additional organizations and individuals who might interact with these groups, including biotechnology, diagnostic, and medical device companies, the life sciences, patent attorneys and patent offices, institutional review boards, ethics review boards, and accreditation organizations.

General Product Information

Published
Document Type	Standard
Status	Current
Publisher	British Standards Institution
Pages
ISBN
Committee	NTI/1